Provided by Tiger Fintech (Singapore) Pte. Ltd.

Profound Medical Corp.

4.78
+0.06001.27%
Post-market: 4.780.00000.00%16:42 EDT
Volume:31.30K
Turnover:149.12K
Market Cap:143.59M
PE:-4.26
High:4.98
Open:4.75
Low:4.61
Close:4.72
Loading ...

Company Profile

Company Name:
Profound Medical Corp.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
142
Office Location:
2400 Skymark Avenue,Unit 6,Mississauga,Ontario,Canada
Zip Code:
L4W 5K5
Fax:
647 847 3739
Introduction:
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, palliative pain treatment of bone metastases, and osteoid osteoma. Profound Medical Corp. is headquartered in Mississauga, Canada.

Directors

Name
Position
Arun Menawat
Chief Executive Officer and Director
Arthur Rosenthal
Director
Brian Ellacott
Director
Jean Francois Pariseau
Director
Kenneth Galbraith
Director
Linda Maxwell
Director
Steve Forte
Director

Shareholders

Name
Position
Arun Menawat
Chief Executive Officer and Director
Aaron Davidson
Chief Financial Officer and Senior Vice President of Corporate Development
Guruprit Singh
Vice President of Regulatory Affairs and Product Management
Mathieu Burtnyk
Vice-President of Clinical Affairs
Rashed Dewan
Vice President of Finance